Effect of statin therapy on the progression of autosomal dominant polycystic kidney disease. A secondary analysis of the HALT PKD trials

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) commonly results in end-stage renal disease (ESRD), yet a long-term treatment that is well tolerated is still lacking. In a small randomized trial in children and adolescents pravastatin administration for 3 years was associated with r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Hypertens Rev
Main Authors: Brosnahan, Godela M., Abebe, Kaleab Z., Rahbari-Oskoui, Frederic F., Patterson, Charity G., Bae, Kyongtae T., Schrier, Robert W., Braun, William E., Chapman, Arlene B., Flessner, Michael F., Harris, Peter C., Perrone, Ronald D., Steinman, Theodore I., Torres, Vicente E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5688015/
https://ncbi.nlm.nih.gov/pubmed/28460625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1573402113666170427142815
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados